In a regulatory filing, Cara Therapeutics (CARA) said it does not hold cash deposits or securities at Silicon Valley Bank (SIVB).
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on CARA:
- Cara Therapeutics downgraded to Underperform from Neutral at BofA
- Cara Therapeutics price target lowered to $22 from $26 at Needham
- Cara Therapeutics price target lowered to $25 from $29 at Canaccord
- Cara Therapeutics price target lowered to $20 from $25 at H.C. Wainwright
- Cara Therapeutics price target lowered to $13 from $25 at Piper Sandler